Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1984 1
1985 3
1989 1
1991 1
1993 1
1995 2
1997 1
2002 1
2003 2
2007 1
2015 1
2018 1
2020 1
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Gladman DD, Mease PJ, Bird P, Soriano ER, Chakravarty SD, Shawi M, Xu S, Quinn ST, Gong C, Leibowitz E, Poddubnyy D, Tam LS, Helliwell PS, Kavanaugh A, Deodhar A, Østergaard M, Baraliakos X. Gladman DD, et al. Among authors: leibowitz e. Trials. 2022 Sep 5;23(1):743. doi: 10.1186/s13063-022-06589-y. Trials. 2022. PMID: 36064592 Free PMC article.
Xeroderma pigmentosum.
Leibowitz E, Janniger CK, Schwartz RA, Lambert WC. Leibowitz E, et al. Cutis. 1997 Aug;60(2):75-7, 81-4. Cutis. 1997. PMID: 9283770 Review. No abstract available.
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé.
Gladman DD, Mease PJ, Bird P, Soriano ER, Chakravarty SD, Shawi M, Lavie F, Gong C, Leibowitz E, Poddubnyy D, Tam LS, Helliwell PS, Kavanaugh A, Deodhar AA, Østergaard M, Baraliakos X. Gladman DD, et al. Among authors: leibowitz e. Ann Rheum Dis. 2022 Apr 29:annrheumdis-2022-222161. doi: 10.1136/annrheumdis-2022-222161. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35487679 No abstract available.
Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.
Orbai AM, Coates LC, Deodhar A, Helliwell PS, Ritchlin CT, Leibowitz E, Kollmeier AP, Hsia EC, Xu XL, Sheng S, Jiang Y, Liu Y, Han C. Orbai AM, et al. Among authors: leibowitz e. Patient. 2022 Nov;15(6):657-668. doi: 10.1007/s40271-022-00588-6. Epub 2022 Jun 30. Patient. 2022. PMID: 35768650 Free PMC article. Clinical Trial.
[Tuberculous choroiditis].
Leibowitz E, Aviel E. Leibowitz E, et al. Harefuah. 1995 Dec 15;129(12):550-2, 615. Harefuah. 1995. PMID: 8682354 Hebrew.
Interferon system in acute transient synovitis.
Leibowitz E, Levin S, Torten J, Meyer R. Leibowitz E, et al. Arch Dis Child. 1985 Oct;60(10):959-62. doi: 10.1136/adc.60.10.959. Arch Dis Child. 1985. PMID: 2415069 Free PMC article.
Are psoriatic patients at risk of heat intolerance?
Leibowitz E, Seidman DS, Laor A, Shapiro Y, Epstein Y. Leibowitz E, et al. Br J Dermatol. 1991 May;124(5):439-42. doi: 10.1111/j.1365-2133.1991.tb00622.x. Br J Dermatol. 1991. PMID: 2039719
23 results